Debarment and ExclusionspersonID: us-fdadq-238de2b9d62ec64b2bc1dd5c029090004a88871d

Alexander Sparkuhl

Primary Source
US FDA RESTRICTED
Coverage
us
Risk Tier
High
Last Updated
2026-07-26

Compliance Profile

"Due Diligence Flag: Alexander Sparkuhl has records on compliance watchlists (US FDA RESTRICTED). Review obligations before proceeding."

Banking Impact

Records on US FDA RESTRICTED can trigger enhanced due diligence, compliance holds, counterparty review and documentation requests from banks, investors or procurement teams.

Legal Status

The record should be reviewed against the original source list, jurisdiction and date of publication before decisions are made. Escalation may be required for procurement, onboarding or investor diligence.

Official Source Metadata

Source: Debarment and Exclusions
Full Legal NameAlexander Sparkuhl
Source Records
US FDA RESTRICTED
Enforcement TypeDebarment and Exclusions
Risk Topicsdebarment

Associated Subject Network

" Ključavničarstvo ",servisiranje in Montaža Miran Vertačnik S.p.
SI CONFLICTS
"Bruma" Vulkanizerstvo in Prodaja Avtoplaščev Matija Brunskole S.p.
SI CONFLICTS
"Centavria" Elektroinštalacije, Posredovanje in Organiziranje Kulturnih Dejavnosti, Posredovanje Pri Prodaji Blaško Goran S.p.
SI CONFLICTS
"Centralvod" Antun Đuran S.p.
SI CONFLICTS

Compliance Context Review

Independent Risk Assessment

SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for individuals seeking to clarify a public record or counterparty signal.

Source-list verification
Banking and counterparty exposure memo
Regulatory status and remediation triage
Request Risk Assessment
Confidential Review
Export PDFSubscriber Only